The integrated PSMA-914 fluorescence intensity peaked at a PSMA-914 dose of 4 nmol and did not significantly change at higher doses, indicating tracer saturation of the tumor tissue at ≤ 4 nmol and the absence of blocking effects up to doses of 10 nmol (Figure 1). The gene discussed is FOLH1; the disease is neoplasm.